{"ChapterHeadings":[{"Title":"Indicator","Url":"/IND12/chapter/indicator"}],"AccreditationList":[],"EndorsementList":[],"SupportingList":[],"ContentPartsList":[{"Url":"/newfeeds/product/IND12/content/1/html","TableOfContents":[{"Url":"/newfeeds/product/IND12/part/1/chapter/indicator","Reference":"IND12","PartId":1,"ChapterSlug":"indicator","Title":"Indicator"}],"Pdf":{"Url":"/newfeeds/downloads/87e39bc6-6c37-46ea-b86e-e180936812d8","Id":"87e39bc6-6c37-46ea-b86e-e180936812d8","MimeType":"application/pdf","FileName":"IND12 Indicator 20240430.pdf","Length":44809,"Hash":"09AF164BCC903384FCF8EB1E63EB3609D2875AC0","Name":"default","Uid":52610716058821},"ETag":null,"Title":"Dementia: anti-psychotic prescriptions","Type":"UploadAndConvertContentPart","Uid":40594688317,"LegacyId":null,"Reference":"IND12","PartId":1}],"RelatedResourceList":[],"RelatedProductList":[],"ETag":"01000000-0000-002A-0000-000000003220","Id":"IND12","LastModified":"2024-05-02T13:36:24.5326395Z","ProductType":"IND","Title":"Dementia: anti-psychotic prescriptions","ShortTitle":null,"InDevReference":"GID-IND10015","MetaDescription":"This indicator covers the proportion of people with dementia prescribed anti-psychotic medication. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG18","Summary":"<p class=\"lead\">This indicator covers the proportion of people with dementia prescribed anti-psychotic medication. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.</p>\n<p><strong>Last reviewed:</strong> March 2024</p>\n<p><strong>Next review:</strong> March 2027</p>\n<p>This indicator will be reviewed using the assessment criteria in <a href=\"https://www.nice.org.uk/guidance/pmg44/chapter/Appendix-B-Criteria-to-appraise-the-validity-of-indicators\">appendix&nbsp;B of the NICE indicators process guide</a> when it reaches its review date or the underlying guidance is updated.</p>\n<p>This indicator was previously published as CCG18.</p>\n<h2>How to use NICE indicators and how we develop them</h2>\n<p>Indicators can be used in a number of different settings to support high quality care. These include:</p>\n<ul>\n<li>identifying where improvements are needed</li>\n<li>setting priorities for quality improvement and support</li>\n<li>creating local performance dashboards</li>\n<li>benchmarking performance against national data</li>\n<li>supporting local quality improvement schemes</li>\n<li>showing progress that local health systems are making on outcomes.</li>\n</ul>\n<p>Find out <a href=\"https://www.nice.org.uk/standards-and-indicators/indicators#how-indicators-are-used\">how&nbsp;to use indicators</a> and <a href=\"https://www.nice.org.uk/standards-and-indicators/indicators#how-we-develop-indicators\">how we develop them</a>.</p>","ProductStatus":"Published","VersionNumber":2,"PublishedDate":"2012-08-01T00:00:00","LastMajorModificationDate":"2024-03-22T00:00:00","MajorChangeDate":"2024-03-22T00:00:00","NextReviewDate":"2027-03-31T00:00:00","CollectionTypesList":[],"AuthorList":["National Institute for Health and Care Excellence (NICE)"],"PublisherList":["National Institute for Health and Care Excellence (NICE)"],"AudienceList":[],"EstimatedSavings":"","EstimatedSavingsDescription":"","EstimatedSavingsImpact":null,"DevelopedAs":null,"RelevantTo":[],"TerminatedAppraisal":null,"AreasOfInterestList":[],"IndicatorSubTypeList":["CCG"],"IndicatorOldCode":"CCG18","IndicatorOldUrl":"https://www.nice.org.uk/standards-and-indicators/ccgoisindicators/dementia-ccg18","TaxonomySubjectList":[],"IPSV":"Health, well-being and care","ProductGroup":"Other","ProductTypeName":"NICE indicator","ProductTypeNamePlural":"NICE indicators"}